Page last updated: 2024-08-21

tetradecyltrimethylammonium and Chronic Hepatitis C

tetradecyltrimethylammonium has been researched along with Chronic Hepatitis C in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Albrecht, J; Blatt, LM; Conrad, A; Dev, A; Heaton, S; McHutchison, JG; Owens, E; Patel, K; Pianko, S; Pockros, PJ	1

Other Studies

1 other study(ies) available for tetradecyltrimethylammonium and Chronic Hepatitis C

Article	Year
The clinical utility of using Catrimox-14-treated whole blood in detecting hepatitis C virus RNA. Antiviral therapy, 2005, Volume: 10, Issue:4 Topics: Adult; Antiviral Agents; Cohort Studies; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Prospective Studies; Quaternary Ammonium Compounds; Recombinant Proteins; Ribavirin; RNA, Viral; Surface-Active Agents; Trimethyl Ammonium Compounds	2005

Article

Year

The clinical utility of using Catrimox-14-treated whole blood in detecting hepatitis C virus RNA.

Antiviral therapy, 2005, Volume: 10, Issue:4

Topics: Adult; Antiviral Agents; Cohort Studies; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Prospective Studies; Quaternary Ammonium Compounds; Recombinant Proteins; Ribavirin; RNA, Viral; Surface-Active Agents; Trimethyl Ammonium Compounds

2005